Published in Neurology on February 01, 1993
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2010) 7.93
Incidence of Dementia over Three Decades in the Framingham Heart Study. N Engl J Med (2016) 5.55
Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med (2008) 5.34
Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res (2012) 4.91
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol (2008) 4.14
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging (2003) 3.50
Overview and findings from the religious orders study. Curr Alzheimer Res (2012) 3.46
Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ (1995) 3.42
Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol (2008) 3.39
The pathobiology of vascular dementia. Neuron (2013) 3.07
The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry (2003) 2.97
Vascular risk factors and dementia: how to move forward? Neurology (2009) 2.97
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med (2008) 2.92
Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study. Brain (2012) 2.64
Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev (2008) 2.62
The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis (2009) 2.54
The protocols for the 10/66 dementia research group population-based research programme. BMC Public Health (2007) 2.54
25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology (2009) 2.39
Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry (2004) 2.32
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol (2010) 2.31
MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology (2001) 2.11
Incidence of dementia among participants and nonparticipants in a longitudinal study of cognitive aging. Am J Epidemiol (2014) 2.09
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease. JAMA Neurol (2015) 2.07
CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol (2011) 2.02
Vitamin D and neurocognitive dysfunction: preventing "D"ecline? Mol Aspects Med (2008) 2.01
Albuminuria and dementia in the elderly: a community study. Am J Kidney Dis (2008) 1.96
Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology (2012) 1.96
Occupational exposure to pesticides increases the risk of incident AD: the Cache County study. Neurology (2010) 1.95
The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.93
Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis. Neurology (2012) 1.90
Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline. J Neurol Neurosurg Psychiatry (2007) 1.88
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology (2009) 1.88
Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid. Biol Psychiatry (2009) 1.85
Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology (2011) 1.84
Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.81
Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities. PLoS Genet (2010) 1.80
The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited. J Alzheimers Dis (2009) 1.78
Neuropsychological assessment of dementia. Annu Rev Psychol (2009) 1.76
Potentially reversible conditions in 1000 consecutive memory clinic patients. J Neurol Neurosurg Psychiatry (2002) 1.73
Depression as a risk factor or prodromal feature for dementia? Findings in a population-based sample of Swedish twins. Psychol Aging (2009) 1.70
Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology (2005) 1.70
Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging (2006) 1.69
Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol (1999) 1.68
Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes (2008) 1.68
Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. Arch Neurol (1999) 1.66
Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy. AJNR Am J Neuroradiol (2000) 1.64
Incidence of dementia and cognitive impairment, not dementia in the United States. Ann Neurol (2011) 1.63
Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study. Arch Neurol (2009) 1.63
Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. CMAJ (1999) 1.60
Diagnosis and treatment of dementia: 2. Diagnosis. CMAJ (2008) 1.55
Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am J Med (2006) 1.52
Late-life depression, mild cognitive impairment, and dementia. JAMA Neurol (2013) 1.52
Visual association test to detect early dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry (2002) 1.48
Postmortem interval effect on RNA and gene expression in human brain tissue. Cell Tissue Bank (2010) 1.46
Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study. Dement Geriatr Cogn Disord (2010) 1.45
White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry (1999) 1.45
Telephone interview for cognitive status: Creating a crosswalk with the Mini-Mental State Examination. Alzheimers Dement (2009) 1.45
Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol (2012) 1.44
Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers. PLoS One (2015) 1.43
Correlations between MRI white matter lesion location and executive function and episodic memory. Neurology (2011) 1.43
Structural network efficiency predicts conversion to dementia. Neurology (2016) 1.41
Alzheimer's disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: difference in cut-off levels from thai experience. Int J Alzheimers Dis (2012) 1.41
Towards improving diagnosis of memory loss in general practice: TIMeLi diagnostic test accuracy study protocol. BMC Fam Pract (2016) 1.40
Neuroimaging in a memory assessment service: a completed audit cycle. Psychiatr Bull (2014) (2014) 1.39
Loss in Executive Functioning Best Explains Changes in Pain Responsiveness in Patients with Dementia-Related Cognitive Decline. Behav Neurol (2015) 1.38
Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health (2014) 1.38
Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. Brain (2011) 1.34
Incidence and prediction of falls in dementia: a prospective study in older people. PLoS One (2009) 1.31
Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. Stroke (2009) 1.30
Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer's disease. Biol Psychiatry (2010) 1.29
Association between late-life body mass index and dementia: The Kame Project. Neurology (2009) 1.28
Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review. BMC Neurol (2006) 1.27
Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci (2013) 1.27
Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia. Arch Neurol (2012) 1.26
Adiposity indicators and dementia over 32 years in Sweden. Neurology (2009) 1.26
Prediction of dementia in primary care patients. PLoS One (2011) 1.25
MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD. Neurology (2008) 1.24
Assessing clinicopathological correlation in chronic traumatic encephalopathy: rationale and methods for the UNITE study. Alzheimers Res Ther (2015) 1.22
Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis (2010) 1.22
Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry (2006) 1.21
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology (2015) 1.21
Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord (2014) 1.21
Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimers Dement (2012) 1.21
Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia. Neurology (2009) 1.19
Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2. Alzheimers Dement (2011) 1.19
Overweight in midlife and risk of dementia: a 40-year follow-up study. Int J Obes (Lond) (2009) 1.19
Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatr (2010) 1.19
Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes (2010) 1.18
The source of cognitive complaints predicts diagnostic conversion differentially among nondemented older adults. Alzheimers Dement (2013) 1.18
Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: the essential role of the neuropathology core. Alzheimers Dement (2010) 1.18
Risk of dementia in elderly patients with the use of proton pump inhibitors. Eur Arch Psychiatry Clin Neurosci (2014) 1.18
Limb length and dementia in an older Korean population. J Neurol Neurosurg Psychiatry (2003) 1.17
Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size. Stroke (2010) 1.16
Temporoparietal MR imaging measures of atrophy in subjects with mild cognitive impairment that predict subsequent diagnosis of Alzheimer disease. AJNR Am J Neuroradiol (2008) 1.15
Retinal vascular caliber and risk of dementia: the Rotterdam study. Neurology (2011) 1.15
Telephone-based identification of mild cognitive impairment and dementia in a multicultural cohort. Arch Neurol (2011) 1.15
Memory failure has different mechanisms in subcortical stroke and Alzheimer's disease. Ann Neurol (2000) 1.14
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain (2015) 1.14
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Influence of education and occupation on the incidence of Alzheimer's disease. JAMA (1994) 8.43
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 7.68
Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology (1999) 7.55
Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 7.51
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (2008) 7.05
Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03
Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci (2000) 6.54
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
The genome of Laccaria bicolor provides insights into mycorrhizal symbiosis. Nature (2008) 5.42
Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med (1995) 5.12
The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med (2000) 5.02
Pathogenesis of leukoaraiosis: a review. Stroke (1997) 4.95
Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol (1998) 4.91
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51
Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke (2001) 3.99
J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet (1994) 3.95
Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology (1999) 3.95
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology (2008) 3.76
Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 3.74
Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology (2002) 3.57
Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology (2008) 3.54
J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension (1999) 3.51
Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology (2012) 3.47
Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol (1999) 3.44
Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ (1995) 3.42
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol (1998) 3.37
Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet (2000) 3.33
The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology (1994) 3.30
Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet (1998) 3.26
A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc (2001) 3.20
Changing views on open-angle glaucoma: definitions and prevalences--The Rotterdam Study. Invest Ophthalmol Vis Sci (2000) 3.19
Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J (1999) 3.18
Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 3.14
Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol (1989) 3.13
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? Int J Geriatr Psychiatry (2001) 3.09
Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. Histopathology (1981) 3.08
The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J (2001) 3.07
A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol (1986) 3.04
The spectrum of behavioral changes in Alzheimer's disease. Neurology (1996) 2.97
Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades. Arch Gen Psychiatry (1999) 2.89
Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex (2001) 2.88
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 2.82
Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82
Incident lacunes influence cognitive decline: the LADIS study. Neurology (2011) 2.81
Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol (1996) 2.80
Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology (2001) 2.80
Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke (1997) 2.79
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2008) 2.72
Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med (1995) 2.70
Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol (1997) 2.67
Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia (2003) 2.66
Subcortical dementia. Review of an emerging concept. Arch Neurol (1984) 2.65
Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet (1994) 2.65
Restriction in complex activities of daily living in MCI: impact on outcome. Neurology (2006) 2.64
Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med (1998) 2.64
Cerebral white matter is highly vulnerable to ischemia. Stroke (1996) 2.62
Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study. Ann Rheum Dis (2011) 2.61
Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ (1994) 2.60
Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci (1994) 2.59
C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation (2005) 2.59
A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam study. Int J Obes Relat Metab Disord (2001) 2.55
Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol (1998) 2.53
Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke (2001) 2.49
The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol (1993) 2.48
Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging (2002) 2.46
Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol (1996) 2.45
Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol (1996) 2.45
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43
Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology (1991) 2.43
Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology (1995) 2.43
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging (1999) 2.41
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Decreased selenium levels in acute myocardial infarction. JAMA (1989) 2.36
Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology (2004) 2.35
Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry (1999) 2.33
A randomized trial of sodium intake and blood pressure in newborn infants. JAMA (1983) 2.32
Hypertension and cerebral white matter lesions in a prospective cohort study. Brain (2002) 2.31
Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke (2003) 2.31
Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol (1998) 2.31
Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology (1995) 2.30
Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (1998) 2.28
Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet (1998) 2.26